Standout Papers

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Ret... 2022 2026 2023 2024104
  1. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study (2022)
    Mingyue Cai, Wensou Huang et al. Frontiers in Immunology

Immediate Impact

60 standout
Sub-graph 1 of 22

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
1 intermediate paper

Works of Jingjun Huang being referenced

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
2021

Author Peers

Author Last Decade Papers Cites
Jingjun Huang 305 105 157 200 34 870
Leonard Kaps 218 54 209 307 60 1.1k
Liteng Lin 254 104 141 356 38 1.0k
Joseph L. Skibba 135 98 92 298 34 887
Reza Khosravan 127 94 71 311 36 1.1k
Maria Rita Emma 74 61 120 443 24 815
Praveen Radhakrishnan 59 42 76 364 35 875
Grete M. Kindberg 83 25 103 352 37 933
Ashutosh Barve 113 116 196 288 25 875
Alexios S Strimpakos 122 78 57 476 34 1.1k
Na Yang 67 25 121 359 42 1.0k

All Works

Loading papers...

Rankless by CCL
2026